Subgroup analysis from the #empagliflozin #RECOVERY trial
Mostly chance for the couple of subgroups I guess? (Less severe disease cc @ChristosArgyrop )
3/
A first for a #Flozin
No benefit with #empagliflozin in #COVID from the #RECOVERY trial
Preprint https://www.medrxiv.org/content/10.1101/2023.04.13.23288469v1.full.pdf+html
1/
#flozin #Empagliflozin #COVID #recovery
EMPA-KIDNEY published last week. #empagliflozin for #CKD seems good (as expected)
https://www.nejm.org/doi/full/10.1056/NEJMoa2204233
Medscape summary: https://www.Medscape.com/virwarticle/983521
#Empagliflozin #Lebensqualität #Herzinsuffizienz
RT @JAMA_current@twitter.com
In this recent trial, empagliflozin improved quality of life and health outcomes as early as 12 weeks after some patients who had heart failure with preserved ejection fracture started treatment. https://ja.ma/3kkDaCF
🐦🔗: https://twitter.com/JAMA_current/status/1520719682139041794
#Empagliflozin #lebensqualität #herzinsuffizienz